Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The glucagon-like peptide-1 receptor--or not?

Literature DB >> 23267050

The glucagon-like peptide-1 receptor--or not?

Charles Pyke, Lotte Bjerre Knudsen.

Abstract

Mesh：

Substances：

Year: 2013 PMID： 23267050 DOI： 10.1210/en.2012-2124

Source DB: PubMed Journal: Endocrinology ISSN： 0013-7227 Impact factor: 4.736

Keyword Cloud
Cited

× No keyword cloud information.

63 in total

Review 1. Glucagon-like peptide 1 (GLP-1).

Authors: T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal: Mol Metab Date: 2019-09-30 Impact factor: 7.422

2. Septal Glucagon-Like Peptide 1 Receptor Expression Determines Suppression of Cocaine-Induced Behavior.

Authors: Anne E Harasta; John M Power; Georg von Jonquieres; Tim Karl; Daniel J Drucker; Gary D Housley; Miriam Schneider; Matthias Klugmann
Journal: Neuropsychopharmacology Date: 2015-02-11 Impact factor: 7.853

3. Localization of Glucagon-Like Peptide-2 Receptor Expression in the Mouse.

Authors: Bernardo Yusta; Dianne Matthews; Jacqueline A Koehler; Gemma Pujadas; Kiran Deep Kaur; Daniel J Drucker
Journal: Endocrinology Date: 2019-08-01 Impact factor: 4.736

4. Different mechanisms involved in liraglutide and glucagon-like peptide-1 vasodilatation in rat mesenteric small arteries.

Authors: Maj Bangshaab; Alejandro Gutierrez; Khiem Dinh Huynh; Jakob Schöllhammer Knudsen; Daniel Dias Rufino Arcanjo; Asbjørn G Petersen; Jørgen Rungby; Michael Gejl; Ulf Simonsen
Journal: Br J Pharmacol Date: 2018-12-09 Impact factor: 8.739

5. Editorial: Antibody can get it right: confronting problems of antibody specificity and irreproducibility.

Authors: Agnes Schonbrunn
Journal: Mol Endocrinol Date: 2014-09

6. Reductions in systolic blood pressure with liraglutide in patients with type 2 diabetes: insights from a patient-level pooled analysis of six randomized clinical trials.

Authors: Vivian A Fonseca; J Hans Devries; Robert R Henry; Morten Donsmark; Henrik F Thomsen; Jorge Plutzky
Journal: J Diabetes Complications Date: 2014-01-21 Impact factor: 2.852

The glucagon-like peptide-1 receptor--or not?

Review 1. Glucagon-like peptide 1 (GLP-1).

2. Septal Glucagon-Like Peptide 1 Receptor Expression Determines Suppression of Cocaine-Induced Behavior.

3. Localization of Glucagon-Like Peptide-2 Receptor Expression in the Mouse.

4. Different mechanisms involved in liraglutide and glucagon-like peptide-1 vasodilatation in rat mesenteric small arteries.

5. Editorial: Antibody can get it right: confronting problems of antibody specificity and irreproducibility.

6. Reductions in systolic blood pressure with liraglutide in patients with type 2 diabetes: insights from a patient-level pooled analysis of six randomized clinical trials.

7. Strict rules are needed for validation of G-protein-coupled receptor immunohistochemical studies in human tissues.

8. GLP-1R activation for the treatment of stroke: updating and future perspectives.

Review 9. Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence.

10. Glucagon-Like Peptide-1 Receptor Expression in Normal and Neoplastic Human Pancreatic Tissues.